|Articles|January 29, 2021
Determine Nitrosamines in Active Pharmaceutical Ingredients
Author(s)Agilent Technologies, Inc.
This application note describes the highly sensitive analysis of nitrosamine impurities in active pharmaceutical ingredients to quantify genotoxic impurities.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Best of the Week: Profiling Endoenous Protein Complexes, Previewing Riva 2026
2
Riva Returns Alive and Kicking
3
Exercise-Induced Gut-Brain Axis Modulation in Autism: Insights from Chromatographic Metabolite Analysis
4
Restek Introduces GC Columns Featuring TriMax Technology for Trace-level Sensitivity
5